Background: New continuous infusion antiepileptic drugs (cIV‐AEDs) offer alternatives to
pentobarbital for the treatment of refractory status epilepticus (RSE). However, no …

Apart from management in a specialised stroke or neurological intensive care unit, until very
recently no specific therapies improved outcome after intracerebral haemorrhage (ICH). In a …

Purpose—Symptomatic intracranial hemorrhage (sICH) is the most feared complication of
intravenous thrombolytic therapy in acute ischemic stroke. Treatment of sICH is based on …

Background Intracerebral hemorrhage is the least treatable form of stroke and is associated
with high mortality. Among patients who undergo computed tomography (CT) within three …

Background Intracerebral hemorrhage is the least treatable form of stroke. We performed
this phase 3 trial to confirm a previous study in which recombinant activated factor VII …

OBJECTIVE: We developed a modification of the Fisher computed tomographic (CT) rating
scale and compared it to the original Fisher scale to determine which scale best predicts …

Background Clazosentan, an endothelin receptor antagonist, significantly and dose-
dependently reduced angiographic vasospasm after aneurysmal subarachnoid …

Objective: Medical complications occur frequently after subarachnoid hemorrhage (SAH).
Their impact on outcome remains poorly defined. Design: Inception cohort study. Patients …

Background and Purpose—Thick cisternal clot on CT is a well-recognized risk factor for
delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH). Whether …

Background and Purpose—Vasospasm is an important complication of subarachnoid
hemorrhage, but is variably defined in the literature. Methods—We studied 580 patients with …